Literature DB >> 7762448

The effects of lactoferrin on gram-negative bacteria.

R T Ellison1.   

Abstract

Lactoferrin is an iron-binding protein found in human mucosal secretions as well as the specific granules of polymorphonuclear leukocytes. A variety of functions have been ascribed to the protein, and it appears to contribute to antimicrobial host defense. In particular, it has been shown to have direct effects on pathogenic microorganisms including bacteriostasis and the induction of microbial iron uptake systems. Still its overall physiologic role remains to be defined. It has appeared logical that antimicrobial activity of the protein arises from sequestration of environmental iron thereby causing nutritional deprivation in susceptible organisms. This argument is buttressed by the finding that selected highly virulent pathogens have evolved techniques to subvert this effect and use the protein as an iron source. However, recent observations indicate that the protein has additional properties that contribute to host defense. Work by several groups has shown that the protein synergistically interacts with immunoglobins, complement, and neutrophil cationic proteins against Gram-negative bacteria. Further, both the whole protein and a cationic N-terminus peptide fragment directly damage the outer membrane of Gram-negative bacteria suggesting a mechanism for the supplemental effects. This review will summarize these diverse observations with a consideration of how the in vitro work relates to the physiological role of the protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7762448     DOI: 10.1007/978-1-4615-2548-6_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  16 in total

Review 1.  Structure and biological actions of lactoferrin.

Authors:  J H Nuijens; P H van Berkel; F L Schanbacher
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-07       Impact factor: 2.673

2.  Usefulness of fecal lactoferrin in predicting and monitoring the clinical severity of infectious diarrhea.

Authors:  Chien-Chang Chen; Chee-Jen Chang; Tzou-Yien Lin; Ming-Wei Lai; Hsun-Chin Chao; Man-Shan Kong
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

3.  Unique host iron utilization mechanisms of Helicobacter pylori revealed with iron-deficient chemically defined media.

Authors:  Olga Senkovich; Shantelle Ceaser; David J McGee; Traci L Testerman
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

Review 4.  Iron homeostasis and eye disease.

Authors:  Allison Loh; Majda Hadziahmetovic; Joshua L Dunaief
Journal:  Biochim Biophys Acta       Date:  2008-11-14

5.  Characterisation of autoantibodies to neutrophil granule constituents among patients with reactive arthritis, rheumatoid arthritis, and ulcerative colitis.

Authors:  H Locht; T Skogh; A Wiik
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

6.  Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.

Authors:  E V Valore; C H Park; A J Quayle; K R Wiles; P B McCray; T Ganz
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

7.  Anti-lactoferrin antibodies and other types of anti-neutrophil cytoplasmic antibodies (ANCA) in reactive arthritis and ankylosing spondylitis.

Authors:  H Locht; T Skogh; E Kihlström
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

8.  Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria.

Authors:  P H Nibbering; E Ravensbergen; M M Welling; L A van Berkel; P H van Berkel; E K Pauwels; J H Nuijens
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

9.  Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide.

Authors:  E Elass-Rochard; A Roseanu; D Legrand; M Trif; V Salmon; C Motas; J Montreuil; G Spik
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

10.  Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11).

Authors:  Walter J F M van der Velden; Thijs M P van Iersel; Nicole M A Blijlevens; J Peter Donnelly
Journal:  BMC Med       Date:  2009-09-08       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.